Shopping Cart
Remove All
Your shopping cart is currently empty
TMIFRY8XAG (4-oxo-1,4-dihydroquinoline-2-carboxylic acid) is a derivative of Zerumbone with potential anti-tumor effects towards HeLa cancer cells.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 5 mg | $55 | Backorder | Backorder | |
| 10 mg | $79 | Backorder | Backorder | |
| 25 mg | $142 | Backorder | Backorder | |
| 50 mg | $202 | Backorder | Backorder | |
| 100 mg | $303 | Backorder | Backorder | |
| 1 mL x 10 mM (in DMSO) | $66 | Backorder | Backorder |
| Description | TMIFRY8XAG (4-oxo-1,4-dihydroquinoline-2-carboxylic acid) is a derivative of Zerumbone with potential anti-tumor effects towards HeLa cancer cells. |
| Synonyms | 4-oxo-1,4-dihydroquinoline-2-carboxylic acid, 1,1'-(4-CHLOROBUTYLIDENE)BIS(4-FLUOROBENZENE) |
| Molecular Weight | 280.74 |
| Formula | C16H15ClF2 |
| Cas No. | 3312-04-7 |
| Smiles | FC1=CC=C(C=C1)C(CCCCl)C1=CC=C(F)C=C1 |
| Relative Density. | 1.2 g/cm3 |
| Color | Transparent |
| Appearance | Viscous |
| Storage | Pure form: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||
| Solubility Information | DMSO: 9 mg/mL (32.06 mM), Sonication is recommended. | |||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.